Ioflupane I-123 Patent Expiration
Ioflupane I-123 was first introduced by Ge Healthcare Inc
Ioflupane I-123 Patents
Given below is the list of patents protecting Ioflupane I-123, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Datscan | US5310912 | Iodinated neuroprobe for mapping monoamine reuptake sites |
Feb 25, 2013
(Expired) | Ge Hlthcare Inc |
Ioflupane I-123's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List